Associated Papers
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes.
Trigos AS et al.
Journal for Immunotherapy of Cancer, 2022
35764368 (PubMed )
Supplement: jitc-2021-003744supp003.pdf
Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.
Willems AJ et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2008
Select a paper to view details